特斯拉自研芯片新进展；禾赛科技启动全球发行丨新鲜早科技

Group 1: Tesla Developments - Elon Musk revealed that Tesla's AI5 chip design has made significant progress, with expectations that it will be an "epic" product, while the upcoming AI6 chip is anticipated to be the best AI chip to date [2] - Tesla's board proposed a new compensation plan for CEO Elon Musk, potentially rewarding him with up to 12% of Tesla's stock, which could be valued at approximately $1.03 trillion if the company reaches an $8.6 trillion market cap [3] Group 2: Regulatory and Market Challenges - The European Union fined Google €29.5 billion for abusing its dominant position in the advertising technology market, impacting competition and requiring Google to submit solutions by early November [4] - Anthropic announced it will stop selling its Claude AI services to companies with majority Chinese ownership, citing compliance with global trade regulations [4] Group 3: Technology and Innovation - Tencent's Hunyuan-MT-7B translation model topped the HuggingFace global model rankings, achieving first place in 30 out of 31 languages in a recent competition [5] - CATL launched its NP3.0 technology platform, claiming it to be the highest safety level in the battery field, with the first product being a lithium iron phosphate battery that prevents fire and smoke during thermal runaway [6] Group 4: Market Performance and Growth - Didi reported an 84% year-on-year increase in car rental orders during the summer, with daily usage reaching 1.7 times last year's peak [8] - Guoke Technology announced contracts totaling over ¥1.278 billion for the mass production of metamaterials with multiple clients [9] Group 5: Corporate Actions and Financial Strategies - HeSai Technology initiated a global offering of 17 million Class B shares, with plans to use the proceeds for R&D and business development [16] - Baidu Group announced plans to issue priority notes denominated in RMB, with proceeds intended for general corporate purposes [17] - Xiangrikui is planning to acquire controlling stakes in two companies, focusing on semiconductor materials and pharmaceuticals, which is expected to constitute a significant asset restructuring [20]